Insider Selling: Huron Consulting Group Inc. (NASDAQ:HURN) Director Sells 2,000 Shares of Stock

Huron Consulting Group Inc. (NASDAQ:HURN - Get Free Report) Director James H. Roth sold 2,000 shares of the firm's stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $126.03, for a total value of $252,060.00. Following the sale, the director now owns 48,534 shares of the company's stock, valued at $6,116,740.02. The trade was a 3.96 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Huron Consulting Group Price Performance

Huron Consulting Group stock traded up $2.99 during mid-day trading on Tuesday, hitting $127.89. 64,705 shares of the company were exchanged, compared to its average volume of 95,484. Huron Consulting Group Inc. has a 1-year low of $84.26 and a 1-year high of $133.96. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82. The business has a fifty day moving average of $124.48 and a 200 day moving average of $115.79. The company has a market capitalization of $2.27 billion, a PE ratio of 27.86 and a beta of 0.59.

Analysts Set New Price Targets

HURN has been the topic of a number of recent research reports. Benchmark restated a "buy" rating and issued a $140.00 target price on shares of Huron Consulting Group in a research note on Wednesday, October 30th. Barrington Research upped their price target on shares of Huron Consulting Group from $137.00 to $142.00 and gave the company an "outperform" rating in a report on Monday, November 4th. StockNews.com upgraded shares of Huron Consulting Group from a "hold" rating to a "buy" rating in a research note on Thursday, October 31st. Finally, Wedbush started coverage on Huron Consulting Group in a research report on Monday, February 3rd. They set an "outperform" rating on the stock. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, Huron Consulting Group has an average rating of "Buy" and a consensus price target of $133.00.

Institutional Investors Weigh In On Huron Consulting Group

A number of hedge funds have recently made changes to their positions in HURN. KLP Kapitalforvaltning AS acquired a new stake in shares of Huron Consulting Group in the fourth quarter valued at $733,000. Hillsdale Investment Management Inc. raised its holdings in Huron Consulting Group by 0.5% in the fourth quarter. Hillsdale Investment Management Inc. now owns 34,060 shares of the business services provider's stock worth $4,232,000 after purchasing an additional 160 shares during the period. American Century Companies Inc. raised its stake in Huron Consulting Group by 2.8% during the 4th quarter. American Century Companies Inc. now owns 148,781 shares of the business services provider's stock worth $18,488,000 after buying an additional 4,041 shares during the period. Semanteon Capital Management LP acquired a new stake in shares of Huron Consulting Group during the fourth quarter worth about $857,000. Finally, Xponance Inc. bought a new position in Huron Consulting Group in the fourth quarter valued at approximately $204,000. Institutional investors and hedge funds own 93.90% of the company's stock.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.